|Rank|Ticker|Approx. Price|Approx. Loss|What is driving it?|
|:-|:-|:-|:-|:-|
|1|**CAPR**|**About $3.10–$3.15**|**−53%**|A major negative reaction following company/FDA-related developments and heavy selling pressure.|
|:-|:-|:-|:-|:-|
|2|**INO**|**$0.59–$0.61**|**−41% to −43%**|Investors are reacting negatively to company developments, creating a high-volume biotech sell-off.|
|:-|:-|:-|:-|:-|
|3|**YAAS**|**$2.00–$2.20**|**−25% to −32%**|Strong selling pressure and momentum liquidation are pushing the low-priced stock lower.|
|:-|:-|:-|:-|:-|
|4|**YYAI**|**About $0.18**|**About −38%**|The stock is under severe penny-stock selling pressure and has moved toward new lows.|
|:-|:-|:-|:-|:-|
|5|**CODX**|**Around $1.44–$1.51**|**Weak/volatile**|The stock has been pressured despite recent diagnostic-test developments; biotech traders remain concerned about execution and financing risk.|
|:-|:-|:-|:-|:-|